Phase III Study of Trifluridine/Tipiracil in Combination With Bevacizumab vs Trifluridine/Tipiracil Single Agent in Patients With Refractory Metastatic Colorectal Cancer
Ontology highlight
ABSTRACT: This study is designed as an international, open-label, controlled two-arm, randomized phase III comparison study evaluating the efficacy and safety of trifluridine/tipiracil in combination with bevacizumab versus trifluridine/tipiracil monotherapy in patients with refractory mCRC.
DISEASE(S): Refractory Metastatic Colorectal Cancer,Colorectal Neoplasms,Colorectal Cancer Metastatic
PROVIDER: 2366035 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA